REPORT OF THE COMMITTEE

Tuesday, April 23, 2013

The Standing Senate Committee on Social Affairs, Science and Technology

has the honour to present its

TWENTY-SECOND REPORT

Your committee, which was authorized by the Senate on Tuesday, November 22, 2011 to examine and report on prescription pharmaceuticals in Canada, respectfully requests funds for the fiscal year ending March 31, 2014.

Pursuant to Chapter 3:06, section 2(1)(c) of the Senate Administrative Rules, the budget submitted to the Standing Committee on Internal Economy, Budgets and Administration and the report thereon of that committee are appended to this report.

Respectfully submitted,

Original signed by:

KELVIN K. OGILVIE

Chair

STANDING COMMITTEE ON
SOCIAL AFFAIRS, SCIENCE AND TECHNOLOGY

SPECIAL STUDY ON PRESCRIPTION PHARMACEUTICALS IN CANADA

APPLICATION FOR BUDGET AUTHORIZATION

FOR THE FISCAL YEAR ENDING MARCH 31, 2014

Extract from the Journals of the Senate, Tuesday, November 22, 2011:

The Honourable Senator Ogilvie, pursuant to notice of November 17, 2011, moved:

That the Senate Standing Committee on Social Affairs, Science and Technology be authorized to examine and report on prescription pharmaceuticals in Canada, including but not limited to:

(a) the process to approve prescription pharmaceuticals with a particular focus on clinical trials;

(b) the post-approval monitoring of prescription pharmaceuticals;

(c) the off-label use of prescription pharmaceuticals; and

(d) the nature of unintended consequences in the use of prescription pharmaceuticals.

That the committee submit its final report no later than December 31, 2013, and that the committee retain until March 31, 2014, all powers necessary to publicize its findings.

The question being put on the motion, it was adopted.

Gary W. O’Brien

Clerk of the Senate

APPENDIX (B) TO THE REPORT

T he Standing Committee on Internal Economy, Budgets and Administration has examined the budget presented to it by the Standing Senate Committee on Social Affairs, Science and Technology for the proposed expenditures of the said Committee for the fiscal year ending March 31, 2014 for the purpose of its special study on prescription pharmaceuticals in Canada, as authorized by the Senate on Tuesday, November 22, 2011. The approved budget is as follows:

Respectfully submitted,

DAVID TKACHUK

Chair